Select Publications

Journal articles

Markoulli M; Ahmad S; Arcot J; Arita R; Benitez-del-Castillo J; Caffery B; Downie LE; Edwards K; Flanagan J; Labetoulle M; Misra SL; Mrugacz M; Singh S; Sheppard J; Vehof J; Versura P; Willcox MDP; Ziemanski J; Wolffsohn JS, 2023, 'TFOS Lifestyle: Impact of nutrition on the ocular surface: TFOS Lifestyle Workshop: Nutrition report', Ocular Surface, 29, pp. 226 - 271,

Tavakoli A; Markoulli M; Papas E; Flanagan J, 2022, 'The Impact of Probiotics and Prebiotics on Dry Eye Disease Signs and Symptoms', Journal of Clinical Medicine, 11,

Tavakoli A; Flanagan JL, 2022, 'Dry eye disease: an (in)convenient truth', Clinical and Experimental Optometry, 105, pp. 222 - 229,

Tavakoli A; Markoulli M; Flanagan J; Papas E, 2022, 'The validity of point of care tear film osmometers in the diagnosis of dry eye', Ophthalmic and Physiological Optics, 42, pp. 140 - 148,

Ang M; Flanagan JL; Wong CW; Müller A; Davis A; Keys D; Resnikoff S; Jong M; Wong TY; Sankaridurg P, 2020, 'Review: Myopia control strategies recommendations from the 2018 WHO/IAPB/BHVI Meeting on Myopia', British Journal of Ophthalmology, 104, pp. 1482 - 1487,

Wong K; Flanagan J; Jalbert I; Tan J, 2019, 'The effect of Blephadex™ Eyelid Wipes on Demodex mites, ocular microbiota, bacterial lipase and comfort: a pilot study', Contact Lens and Anterior Eye, 42, pp. 652 - 657,

Tavakoli A; Flanagan JL, 2019, 'The case for a more holistic approach to dry eye disease: Is it time to move beyond antibiotics?', Antibiotics, 8,

Flanagan J; Fricke T; Morjaria P; Yasmin S, 2019, 'Myopia: A growing epidemic', Community Eye Health Journal, 32, pp. 9 - 9,

Flanagan JL; Souza ND, 2018, 'Simulation in ophthalmic training', Asia-Pacific Journal of Ophthalmology, 7, pp. 427 - 435,

Lee L; Garrett Q; Flanagan J; Chakrabarti S; Papas E, 2018, 'Genetic factors and molecular mechanisms in dry eye disease', Ocular Surface, 16, pp. 206 - 217,

Markoulli M; Flanagan J; Tummanapalli SS; Wu J; Willcox M, 2018, 'The impact of diabetes on corneal nerve morphology and ocular surface integrity', Ocular Surface, 16, pp. 45 - 57,

Lee L; Garrett Q; Flanagan JL; Vaddavalli PK; Papas EB, 2016, 'Treatment practices and outcomes of meibomian gland dysfunction at a tertiary center in southern India', Eye and Contact Lens, 44, pp. S138 - S143,

Flanagan JL; Khandekar N; Zhu H; Watanabe K; Markoulli M; Flanagan JT; Papas E, 2016, 'Glycerol monolaurate inhibits lipase production by clinical ocular isolates without affecting bacterial cell viability', Investigative Ophthalmology and Visual Science, 57, pp. 544 - 550,

Garrett Q; Khandekar N; Shih S; Flanagan JL; Simmons P; Vehige J; Willcox MD, 2013, 'Betaine stabilizes cell volume and protects against apoptosis in human corneal epithelial cells under hyperosmotic stress', Experimental Eye Research, 108, pp. 33 - 41,

De Souza N; Cui Y; Looi S; Paudel P; Shinde L; Kumar K; Berwal R; Wadhwa R; Daniel V; Flanagan J; Holden B, 2012, 'The role of optometrists in India: An integral part of an eye health team', Indian Journal of Ophthalmology, 60, pp. 401 - 405,

Conibear T; Willcox MD; Flanagan JL; Zhu H, 2012, 'Characterization of protease IV expression in Pseudomonas aeruginosa clinical isolates', Journal of Medical Microbiology, 61, pp. 180 - 190,

Lynch SV; Flanagan JL; Sawa T; Fang A; Baek MS; Rubio-Mills A; Ajayi T; Yanagihara K; Hirakata Y; Kohno S; Misset B; Nguyen J-C; Wiener-Kronish JP, 2010, 'Polymorphisms in the Pseudomonas aeruginosa type III secretion protein, PcrV - implications for anti-PcrV immunotherapy.', Microb Pathog, 48, pp. 197 - 204,

Carney FP; Morris C; Milthorpe BK; Flanagan JL; Willcox MD, 2009, 'In vitro adsorption of tear proteins to hydroxyethyl methacrylate-based contact lens materials', Eye and Contact Lens, 35, pp. 320 - 328

Flanagan JL; Willcox MD, 2009, 'Role of lactoferrin in the tear film', Biochimie, 91, pp. 35 - 43

Hume EB; Flanagan JL; Masoudi S; Zhu H; Cole NA; Willcox MD, 2009, 'Soft contact lens disinfection solution efficacy: Clinical Fusarium isolates vs. ATCC 36031', Optometry and Vision Science, 86, pp. 415 - 419

Wong-Beringer A; Wiener-Kronish J; Lynch S; Flanagan J, 2008, 'Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa.', Clin Microbiol Infect, 14, pp. 330 - 336,

Garrett Q; Xu S; Simmons P; Vehige J; Flanagan JL; Willcox MD, 2008, 'Expression and Localization of Carnitine/Organic Cation Transporter OCTN1 and OCTN2 in Ocular Epithelium', Investigative Ophthalmology and Visual Science, 49, pp. 4844 - 4849

Song Y; Wiener-Kronish JP; Flanagan J; Lynch SV, 2007, 'Alveolar hemostasis in patients with species-specific bacterial-mediated ventilator-associated pneumonia.', Crit Care Med, 35, pp. 652 - 653,

Song Y; Lynch SV; Flanagan J; Zhuo H; Tom W; Dotson RH; Baek MS; Rubio-Mills A; Singh G; Kipnis E; Glidden D; Brown R; Garcia O; Wiener-Kronish JP, 2007, 'Increased plasminogen activator inhibitor-1 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa.', Anesthesiology, 106, pp. 252 - 261,

Flanagan JL; Brodie EL; Weng L; Lynch SV; Garcia O; Brown R; Hugenholtz P; DeSantis TZ; Andersen GL; Wiener-Kronish JP; Bristow J, 2007, 'Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa.', J Clin Microbiol, 45, pp. 1954 - 1962,

Augustin DK; Song Y; Baek MS; Sawa Y; Singh G; Taylor B; Rubio-Mills A; Flanagan JL; Wiener-Kronish JP; Lynch SV, 2007, 'Presence or absence of lipopolysaccharide O antigens affects type III secretion by Pseudomonas aeruginosa.', J Bacteriol, 189, pp. 2203 - 2209,

Baker BJ; Tyson GW; Webb RI; Flanagan J; Hugenholtz P; Allen EE; Banfield JF, 2006, 'Lineages of acidophilic archaea revealed by community genomic analysis.', Science, 314, pp. 1933 - 1935,

Esteban L; Fong C; Amr D; Cock T; Allison SJ; Flanagan JL; Liddle C; Eisman JA; Gardiner EM, 2005, 'Promoter-, cell-, and ligand-specific transactivation responses of the VDRB1 isoform', Biochemical and Biophysical Research Communications, 334, pp. 9 - 15,

Esteban L; Cock T; Allison SJ; Flanagan JL; Amr D; Liddle C; Eisman JA; Gardiner EM, 2004, 'Cell-, promoter- and ligand-specific transactivation responses of the VDRB1 isoform', Journal of Bone and Mineral Research, 19, pp. S198 - S198

Gardiner EM; Esteban L; Fong C; Allison SJ; Flanagan JL; Kouzmenko AP; Eisman JA, 2004, 'Vitamin D receptor B1 and exon 1d: functional and evolutionary analysis', Journal of Steroid Biochemistry and Molecular Biology, 89-90, pp. 233 - 238,

Flanagan JL; Leong GM; Subramaniam N; Cock T; Crofts LA; Eisman JA; Gardiner EM; Kouzmenko AP, 2000, 'A novel N-terminally extended isoform of the human VDR harbours an AF-1 domain and interacts with transcriptional co-factors.', JOURNAL OF BONE AND MINERAL RESEARCH, 15, pp. S199 - S199,

Leong GM; Subramaniam N; Flanagan JL; Eisman JA; Kouzmenko AP, 2000, 'Skip, the nuclear hormone receptor co-factor interacts with Smad3 to activate transforming growth factor-beta signalling.', JOURNAL OF BONE AND MINERAL RESEARCH, 15, pp. S328 - S328,

Subramaniam N; Leong GM; Flanagan JL; Cock T; Eisman JA; Kouzmenko AP, 2000, 'Transcriptional synergism of 1, 25-dihydroxyvitamin D-3 and transforming growth factor-beta signalling requires simultaneous binding of VDR and Smad3 proteins to their cognate DNA recognition elements.', JOURNAL OF BONE AND MINERAL RESEARCH, 15, pp. S190 - S190,

Leong GM; Subramaniam N; Flanagan JL; Eisman JA; Gardiner EM; Kouzmenko AP, 2000, 'Transforming growth factor-β signalling through the nuclear cofactor skip', Bone, 27, pp. 18 - 18,

Hu Y; Flanagan J; Brennan DP; Zhou H; Ng KW; Eisman JA; Morrison NA, 1995, 'rHox: A homeobox gene expressed in osteoblastic cells', Journal of Cellular Biochemistry, 59, pp. 486 - 497,

Schedlich LJ; Flanagan JL; Crofts LA; Gillies SA; Goldberg D; Morrison NA; Eisman JA, 1994, 'Transcriptional activation of the human osteocalcin gene by basic fibroblast growth factor', Journal of Bone and Mineral Research, 9, pp. 143 - 152,

Flanagan JL; Ventra L; Weiss AS, 1989, 'Rapid method for preparation and cleavage of bacterial DNA for pulsed-field gel electrophoresis.', Nucleic Acids Res, 17, pp. 814,

Back to profile page